News

The government identified the man as the president of Noor Inc., a supplier of merchandise to convenience stores across New ...
The administration said it is fast-tracking clinical trials that would allow patients struggling with serious mental health ...
The FDA awarded orphan drug designation to VT3989 for mesothelioma, supporting the experimental cancer treatment’s ...
Trethera Corporation (“Trethera”), a clinical stage biopharmaceutical company developing first-in-class therapies for cancer ...
AbbVie is seeking a new way to fight chronic lymphocytic leukemia by combining its oncology drug Venclexta with another ...
For decades, the idea that food could be addictive was considered fringe. In 2017, when Gearhardt presented her research at a ...
With Health Secretary Robert F. Kennedy Jr. publicly calling out Big Food, ultra-processed foods are finally entering the ...
Vitamin D supplements help to fill the gaps, but that can come at a cost if they’re taken with certain medications. “Like any ...
Eisai and Biogen's Alzheimer's drug Leqembi continued to slow progress of the disease with no new safety issues four years ...
Whether you’re talking to a partner, a friend, or your doctor, weight loss can be a sensitive topic. And if you’re thinking ...
Madrigal Pharmaceuticals said on Wednesday it has entered into an up to $2 billion global license agreement with CSPC Pharmaceutical to develop an oral GLP-1 drug for a type of liver disease. The U.S.